Back

Development of a Polyelectrolyte Complex Scaffold and its specific cell seeding method as a tool for liquid cancers drug screening

Grossemy, S. E.; Cadot, S.; Farno, M.; Cavalie, S.; Sallerin, B.; Ysebaert, L.; Quillet-Mary, A.; Girod Fullana, S.

2026-05-05 bioengineering
10.64898/2026.04.30.722037 bioRxiv
Show abstract

This study focuses on the development of 3D culture model dedicated to liquid cancers drug screening. The challenge addressed was to effectively retain non adherent small cells within a 3D-scaffold with tailorable mechanical properties, while proposing a fast and effective tool for drug screening. To that aim, we developed a macroporous alginate-chitosan polyelectrolyte complex (PEC) scaffold combined with a low-viscosity alginate (LVA) cell seeding solution. We hypothesized that LVA could undergo in situ pore gelation via calcium ions retained from the PEC fabrication process, enabling effective retention and homogeneous cell distribution, leading to an improved platform for drug screening and personalized medicine. First, we evaluated scaffold suitability for LVA infiltration and gelation. Microtomography revealed a highly porous architecture (98%) enabling LVA homogeneous penetration and complete gelation within 30 min, as confirmed by SEM, microscopy, rheology, and micro-rheology. Next, we assessed cell retention and biocompatibility using primary human chronic lymphocytic leukemia (CLL) cells. LVA-assisted seeding increased cell density 2.6-fold compared to medium alone, with homogeneous distribution, >80% viability over 7 days, and preserved differentiation into nurse-like cells. Finally, we demonstrated a proof of concept for drug screening. The Alginate-PEC scaffold (A-PEC scaffold) supported both qualitative live/dead imaging and rapid quantitative viability measurement with the Alamar Blue assay. Drug responses reproduced microenvironment-dependent protection effects observed in vivo. This integrated scaffold and seeding method provides a promising 3D platform for in vitro liquid cancer studies and drug screening on patient-derived hematological cancer cells. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=67 SRC="FIGDIR/small/722037v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@9b71d4org.highwire.dtl.DTLVardef@14e1dd0org.highwire.dtl.DTLVardef@1876a56org.highwire.dtl.DTLVardef@15656bc_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Advanced Healthcare Materials
71 papers in training set
Top 0.1%
18.3%
2
Biomaterials Science
21 papers in training set
Top 0.1%
7.0%
3
Bioactive Materials
18 papers in training set
Top 0.1%
6.3%
4
Biomaterials Advances
20 papers in training set
Top 0.1%
6.2%
5
Materials Today Bio
18 papers in training set
Top 0.1%
4.2%
6
Advanced Functional Materials
41 papers in training set
Top 0.6%
4.2%
7
Advanced Science
249 papers in training set
Top 6%
3.5%
8
Biofabrication
32 papers in training set
Top 0.3%
3.5%
50% of probability mass above
9
Bioengineering & Translational Medicine
21 papers in training set
Top 0.2%
3.0%
10
Advanced Materials
53 papers in training set
Top 0.8%
3.0%
11
ACS Biomaterials Science & Engineering
37 papers in training set
Top 0.3%
3.0%
12
Scientific Reports
3102 papers in training set
Top 51%
2.0%
13
Journal of Biomedical Materials Research Part A
18 papers in training set
Top 0.2%
1.9%
14
ACS Applied Materials & Interfaces
39 papers in training set
Top 0.4%
1.9%
15
Biotechnology and Bioengineering
49 papers in training set
Top 0.5%
1.7%
16
ACS Applied Bio Materials
21 papers in training set
Top 0.4%
1.7%
17
Biomacromolecules
25 papers in training set
Top 0.2%
1.7%
18
Advanced Materials Technologies
27 papers in training set
Top 0.4%
1.5%
19
Acta Biomaterialia
85 papers in training set
Top 0.6%
1.5%
20
ACS Omega
90 papers in training set
Top 2%
1.5%
21
Advanced Therapeutics
15 papers in training set
Top 0.3%
1.3%
22
Cytotherapy
14 papers in training set
Top 0.2%
1.3%
23
Lab on a Chip
88 papers in training set
Top 0.9%
1.1%
24
Advanced Biology
29 papers in training set
Top 0.8%
0.9%
25
Journal of Controlled Release
39 papers in training set
Top 0.9%
0.9%
26
Small Methods
26 papers in training set
Top 1%
0.7%
27
Small
70 papers in training set
Top 1%
0.7%
28
PLOS ONE
4510 papers in training set
Top 68%
0.7%
29
Pharmaceutics
21 papers in training set
Top 0.5%
0.7%
30
Biomaterials
78 papers in training set
Top 1%
0.7%